A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL) | MicrobiomeTrials← Back to trialsNCT06789159
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2028-10-01
Enrollment target: 30 participants Locations- University of Kentucky, Lexington, Kentucky, United States
Other microbiome trials you might be interested in
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
An open-label, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplat…
Graz, AustriaCompleted Dec 19, 2025
Diffuse Large B-cell Lymphoma
In the current protocol version, there are two parts. Part I is a pivotal Phase II randomised, multi-centre, open-label …
Graz, AustriaEst. completion Jan 15, 2025